Showing results (81-90 of 100) with videos related to
Sort By:
Pageof 10
Vaccine|April 27, 2000
Effective mucosal immunization against respiratory syncytial virus using purified F protein and a genetically detoxified cholera holotoxin, CT-E29HP W Tebbey, C A Scheuer, J A Peek, et al.Archives of Pathology & Laboratory Medicine|October 1, 1983
Age-related changes in T- and B-lymphocyte subpopulations in the peripheral bloodM J Hicks, J F Jones, L L Minnich, et al.JAMA|October 2, 1981
In utero Epstein-Barr virus (infectious mononucleosis) infectionG N Goldberg, V A Fulginiti, C G Ray, et al.Population Health Metrics|March 15, 2016
Methods of applying the 1994 case definition of chronic fatigue syndrome - impact on classification and observed illness characteristicsE R Unger, J-M S Lin, H Tian, et al.Lancet (London, England)|July 18, 1981
Treatment of childhood combined Epstein-Barr virus/cytomegalovirus infection with oral bovine transfer factorJ F Jones, L L Minnich, W S Jeter, et al.Brain, Behavior, and Immunity|June 1, 1991
Stress-related activation of Epstein-Barr virusR Glaser, G R Pearson, J F Jones, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 29, 2000
Analysis and significance of anti-latent membrane protein-1 antibodies in the sera of patients with EBV-associated diseasesJ Xu, A Ahmad, M D'Addario, et al.International Journal of Cancer|October 7, 1998
The Epstein-Barr virus (EBV) major envelope glycoprotein gp350/220-specific antibody reactivities in the sera of patients with different EBV-associated diseasesJ Xu, A Ahmad, M Blagdon, et al.The Journal of Pediatrics|October 1, 1986
Noma in children with severe combined immunodeficiencyH A Rotbart, M J Levin, J F Jones, et al.Journal of Clinical Immunology|January 1, 1983
Serum interferon in Navajo children with severe combined immunodeficiency disease inhibits lymphoblastogenesisJ F Jones, L M Minnich, D O Lucas, et al.Pageof 10